Reimagining Preexposure Prophylaxis Provision for Women in the United States

Dominika Seidman; Rachel Logan; Shannon Weber; Anisha Gandhi; Oni Blackstock

doi:10.1093/cid/ciab959

Reimagining Preexposure Prophylaxis Provision for Women in the United States

Clin Infect Dis. 2022 Jul 6;74(12):2243-2248. doi: 10.1093/cid/ciab959.

Authors

Dominika Seidman¹, Rachel Logan², Shannon Weber³, Anisha Gandhi⁴, Oni Blackstock⁵

Affiliations

¹ Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, California, USA.
² Family and Community Medicine, University of California San Francisco, San Francisco, California, USA.
³ San Francisco, California, USA.
⁴ Racial Equity and Social Justice Initiatives, Bureau of HIV, New York City Department of Health and Mental Hygiene, New York, New York, USAand.
⁵ Health Justice, New York, New York, USA.

Abstract

Structural determinants of health drive inequities in the acquisition of human immunodeficiency virus (HIV) and the use of preexposure prophylaxis (PrEP) for HIV prevention among cisgender women in the United States. However, current PrEP clinical guidance and implementation paradigms largely focus on individual behaviors and characteristics, resulting in missed opportunities to improve PrEP access, and the implicit transferring of prevention work from health systems to individuals. In this viewpoint article, we outline ways to apply a structural lens to clinical guidance and PrEP implementation for women and propose areas for future work.

Keywords: HIV; PrEP; equity; structural determinants; women.

Publication types

Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Anti-HIV Agents* / therapeutic use
Female
HIV Infections* / drug therapy
HIV Infections* / prevention & control
Humans
Pre-Exposure Prophylaxis* / methods
United States

Substances

Anti-HIV Agents

Grants and funding

K12 HD001262/HD/NICHD NIH HHS/United States